Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PETX - Aratana (PETX) Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Aratana Therapeutics Inc. is Fair to Shareholders - PETX


PETX - Aratana (PETX) Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Aratana Therapeutics Inc. is Fair to Shareholders - PETX

NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the sale of Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (NASDAQ: PETX) to Elanco Animal Health (“Elanco”) is fair to Aratana shareholders.

If you are an Aratana shareholder and would like to discuss your legal rights and options, please visit Aratana (PETX) Merger Investigation or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

On April 26, 2019, HC Wainwright set a target price for Aratana at $5.00 per share, or 10% higher than Elanco’s offer valued at $4.75 per share. The investigation concerns whether Aratana and its Board of Directors violated the federal securities laws and/or their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Aratana shareholders; (2) determine whether Elanco is underpaying for Aratana; and (3) disclose all material information necessary for Aratana shareholders to adequately assess and value the merger consideration.

On behalf of Aratana shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

If you are an Aratana shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/aratana-therapeutics-inc-petx-merger-elanco-stock/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represent investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Stock Information

Company Name: Aratana Therapeutics Inc.
Stock Symbol: PETX
Market: NASDAQ
Website: aratana.com

Menu

PETX PETX Quote PETX Short PETX News PETX Articles PETX Message Board
Get PETX Alerts

News, Short Squeeze, Breakout and More Instantly...